Skip to content

Endoscopic-Assisted Versus Conventional Crestal Sinus Lift

Clinical and Radiographic Evaluation of Endoscopic-Assisted Versus Conventional Crestal Sinus Lift: A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07824037
Acronym
sinus lift
Enrollment
24
Registered
2026-09-17
Start date
2026-05-25
Completion date
2028-07-31
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Defects

Keywords

Maxillary sinus augmentation, Posterior maxillary implants, Sinus endoscopy

Brief summary

To compare Endoscopic-Assisted Versus Conventional Crestal Sinus Lift; bone grafting will be performed, followed by implant placement. Membrane perforation rates, surgical time, and bone density changes will be evaluated.

Detailed description

Type of study design: A Randomized Clinical Trial Objective of the research: To compare Endoscopic-Assisted Versus Conventional Crestal Sinus Lift; bone grafting will be performed, followed by implant placement. Membrane perforation rates, surgical time, and bone density changes will be evaluated. Steps of the research in short including the following: • The inclusion and exclusion criteria for patient selection. Inclusion criteria: Loss of one or more maxillary posterior tooth, Patients age≥21 years, Bone height was 4-7 mm, sufficient inter-arch space and mesio-distal width. Exclusion criteria Parafunctional habits, Drug or alcohol abuse, uncontrolled systemic diseases that contraindicate implant surgery, pregnant women, Smokers. * Mention the source of the patients enrolled in the research All patients will be operated on and followed up at the Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University, Egypt. * A written informed consent form will be signed from the patientis required. * Description of the methodology. Radiographic assessment involved panoramic X-rays and cone-beam computed tomography (CBCT). CBCT analysis included evaluation of residual bone height, buccopalatal bone width, sinus pathology, bony septa, and precise measurement of Schneiderian membrane thickness at the planned implant sites Group 1(non-endoscopic-guided): Endoscopic evaluation was performed after complete osteotomy preparation and sinus membrane elevation using osteotomes. Group 2 (Endoscopic-guided): Endoscopic evaluation was conducted after each drilling step, osteotome malleting, and bone graft placement to monitor sinus membrane integrity. Sample size calculation. * Randomization in case of RCT. Patients will be divided into two groups based on treatment type using block randomization of block size 4. An independent statistician will generate the random sequence using a computer-generated random number list method by (https://www.randomizer.org/). * Number of visits & follow up period. ( 4 visits) Patients in both groups will be followed up at 24-hours, one, three, six, months postoperatively to assess this parameter: 1. Membrane integrity intraoperative. 2. Surgical intraoperative time. 3. Radiographically, mean bone density will be measured (immediate post-operative and post 6 months CBCT)

Interventions

PROCEDUREEndoscopic-guided Sinus lift

12 patients in Group 2 (Endoscopic-guided): Endoscopic evaluation was conducted after each drilling step, osteotome malleting, and bone graft placement to monitor sinus membrane integrity.

PROCEDUREnon- endoscopic sinus lift

12 patients in Group 1(non-endoscopic-guided): Endoscopic evaluation was performed after complete osteotomy preparation and sinus membrane elevation using osteotomes.

Sponsors

Nahla Mahmoud Awad
Lead SponsorOTHER
Cairo University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Loss of one or more maxillary posterior tooth, Patients age≥21 years, Bone height was 4-7 mm, sufficient inter-arch space and mesio-distal width.

Exclusion criteria

* Parafunctional habits, Drug or alcohol abuse, uncontrolled systemic diseases that contraindicate implant surgery, pregnant women, Smokers.

Design outcomes

Primary

MeasureTime frameDescription
Membrane integrity intraoperative.24 hoursMembrane remains intact ( no perforation)

Secondary

MeasureTime frameDescription
mean bone density6 monthsCBCT

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026